Smith & Nephew (SNN) Restructuring Costs (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Restructuring Costs of -$47.0 million for Q4 2025, up 61.79% year-on-year from -$29.1 million in Q4 2024, and up 61.79% on a QoQ basis from -$123.0 million in Q4 2024.
Smith & Nephew (SNN) Restructuring Costs (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Restructuring Costs for 13 consecutive years, with -$47.0 million the latest figure, recorded in Q4 2025.
- Quarterly Restructuring Costs rose 61.79% year-over-year to -$47.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$61.0 million (down 279.41% YoY) and the FY2025 annual result came in at -$47.0 million, up 61.79% from the prior year.
- Restructuring Costs grew to -$47.0 million in Q4 2025 per SNN's latest filing, from -$123.0 million in the prior quarter.
- Over the last five years, Restructuring Costs for SNN reached as high as $63.0 million in Q4 2022 and fell as low as -$123.0 million in Q4 2024.
- A 4-year average of -$15.2 million and a median of -$500000.0 in 2023 frame the typical range for Restructuring Costs.
- Annual changes were most pronounced in 2024 — Restructuring Costs plunged 367.39% — and 2025, when it jumped 61.79%.
- Year by year, Restructuring Costs stood at $63.0 million in 2022, then decreased by 26.98% to $46.0 million in 2023, then tumbled by 367.39% to -$123.0 million in 2024, then soared by 61.79% to -$47.0 million in 2025.
- According to Business Quant data, Restructuring Costs over the past three periods registered -$47.0 million, -$123.0 million, and $46.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -47.00 Mn |
| Dec 31, 2024 | -123.00 Mn |
| Dec 31, 2023 | 46.00 Mn |
| Dec 31, 2022 | 63.00 Mn |
| Dec 31, 2019 | 48.00 Mn |
| Dec 31, 2018 | 58.00 Mn |
| Dec 31, 2015 | 65.00 Mn |
| Dec 31, 2014 | 61.00 Mn |
| Dec 31, 2013 | 22.00 Mn |
| Mar 31, 2013 | 22.00 Mn |
| Dec 31, 2012 | 6.00 Mn |
| Jun 30, 2012 | -15.00 Mn |
| Mar 31, 2012 | 35.00 Mn |
| Dec 31, 2011 | 33.00 Mn |
| Sep 30, 2011 | 7.00 Mn |
| Jun 30, 2011 | -5.00 Mn |
| Mar 31, 2011 | 5.00 Mn |
| Dec 31, 2010 | 15.00 Mn |
| Sep 30, 2010 | 1.00 |
| Jun 30, 2010 | 10.00 |